Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Varenicline | hsa00030 | Pentose phosphate pathway | 1.08E-05 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Varenicline | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Varenicline | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Varenicline | hsa00190 | Oxidative phosphorylation | 4.38E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Varenicline | hsa00220 | Arginine biosynthesis | 3.83E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Varenicline | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Varenicline | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Varenicline | hsa00350 | Tyrosine metabolism | 3.40E-02 | 1 | P28332 | ADH6 | More | | Varenicline | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Varenicline | hsa00565 | Ether lipid metabolism | 3.00E-03 | 1 | Q8N661 | TMEM86B | More | | Varenicline | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Varenicline | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Varenicline | hsa00600 | Sphingolipid metabolism | 2.44E-02 | 2 | Q9BX95, Q06136 | SGPP1, FVT1 | More | | Varenicline | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Varenicline | hsa00670 | One carbon pool by folate | 1.32E-02 | 1 | P00374 | DHFR | More | | Varenicline | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Varenicline | hsa00740 | Riboflavin metabolism | 4.77E-02 | 1 | P30043 | BLVRB | More | | Varenicline | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Varenicline | hsa00785 | Lipoic acid metabolism | 4.32E-02 | 1 | Q9Y234 | LIPT1 | More | | Varenicline | hsa00790 | Folate biosynthesis | 1.32E-02 | 1 | P00374 | DHFR | More | | Varenicline | hsa00830 | Retinol metabolism | 2.51E-03 | 4 | P00325, P00352, Q9BPW9, O75911 | ADH1B, ALDH1A1, DHRS9, DHRS3 | More | | Varenicline | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Varenicline | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Varenicline | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 8.40E-04 | 3 | P78417, P28332, P11712 | GSTO1, ADH6, CYP2C9 | More | | Varenicline | hsa00982 | Drug metabolism - cytochrome P450 | 8.40E-04 | 3 | P11712, P78417, P28332 | CYP2C9, GSTO1, ADH6 | More | | Varenicline | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Varenicline | hsa01230 | Biosynthesis of amino acids | 2.22E-03 | 4 | P51854, P60891, Q99707, P37837 | TKTL1, PRPS1, MTR, TALDO1 | More | | Varenicline | hsa01523 | Antifolate resistance | 2.64E-03 | 3 | Q92820, P04818, P00374 | GGH, TYMS, DHFR | More | | Varenicline | hsa01524 | Platinum drug resistance | 4.57E-02 | 1 | P20585 | MSH3 | More | | Varenicline | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Varenicline | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Varenicline | hsa03013 | RNA transport | 4.13E-07 | 12 | O14980, P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, Q14240, Q9BZI7, P23588, Q9Y6A5, Q06787 | XPO1, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF4A2, UPF3B, EIF4B, TACC3, FMR1 | More | | Varenicline | hsa03015 | mRNA surveillance pathway | 1.93E-03 | 5 | Q9BZI7, Q13362, Q14738, O94913, Q9UBU9 | UPF3B, PPP2R5C, PPP2R5D, PCF11, NXF1 | More | | Varenicline | hsa03020 | RNA polymerase | 9.82E-08 | 5 | P30876, P24928, P62487, Q9GZM3, P52435 | POLR2B, POLR2A, POLR2G, POLR2J2, POLR2J | More | | Varenicline | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Varenicline | hsa03060 | Protein export | 2.58E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Varenicline | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Varenicline | hsa03410 | Base excision repair | 7.59E-03 | 1 | P27695 | APEX1 | More | | Varenicline | hsa03430 | Mismatch repair | 3.93E-02 | 1 | P20585 | MSH3 | More | | Varenicline | hsa03450 | Non-homologous end-joining | 3.17E-03 | 2 | Q9NP87, P13010 | POLM, XRCC5 | More | | Varenicline | hsa04010 | MAPK signaling pathway | 1.53E-02 | 2 | Q9H2K8, Q12933 | TAOK3, TRAF2 | More | | Varenicline | hsa04020 | Calcium signaling pathway | 8.47E-03 | 6 | Q13557, P61073, P0DP24, P05141, P51828, P63092 | CAMK2D, CXCR4, CALM2, SLC25A5, ADCY7, GNAS | More | | Varenicline | hsa04022 | cGMP-PKG signaling pathway | 2.55E-02 | 4 | P18848, Q8WYR1, P05141, P0DP24 | ATF4, PIK3R5, SLC25A5, CALM2 | More | | Varenicline | hsa04060 | Cytokine-cytokine receptor interaction | 5.34E-03 | 11 | P14784, P27930, P14778, P26842, Q06643, Q13651, P25024, Q9UBD3, P47992, P09341, P01730 | IL2RB, IL1R2, IL1R1, CD27, LTB, IL10RA, CXCR1, XCL2, XCL1, CXCL1, CD4 | More | | Varenicline | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.70E-03 | 8 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB | More | | Varenicline | hsa04062 | Chemokine signaling pathway | 4.01E-04 | 13 | P25024, P25025, P09341, P19875, P47992, Q9UBD3, P07948, P42338, P19174, P63218, P50151, P43250, Q08881 | CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, ITK | More | | Varenicline | hsa04064 | NF-kappa B signaling pathway | 6.52E-06 | 20 | P10415, Q13489, O00463, P14778, P01584, P29965, P19174, Q04759, Q9UDY8, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, TRAF5, IL1R1, IL1B, CD40LG, PLCG1, PRKCQ, MALT1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Varenicline | hsa04070 | Phosphatidylinositol signaling system | 2.98E-03 | 6 | P0DP23, Q14643, P23743, Q86XP1, Q96DU7, P17252 | CALM1, ITPR1, DGKA, DGKH, ITPKC, PRKCA | More | | Varenicline | hsa04071 | Sphingolipid signaling pathway | 1.65E-04 | 9 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q12933, Q02156 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, TRAF2, PRKCE | More | | Varenicline | hsa04072 | Phospholipase D signaling pathway | 5.38E-03 | 10 | P42338, Q9UQC2, P43657, P25024, P25025, P19174, Q8WYR1, P63092, P51828, Q16760 | PIK3CB, GAB2, P2RY5, CXCR1, CXCR2, PLCG1, PIK3R5, GNAS, ADCY7, DGKD | More | | Varenicline | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Varenicline | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Varenicline | hsa04114 | Oocyte meiosis | 5.93E-06 | 12 | Q9Y6D9, P51812, Q02750, Q13557, P0DP23, P0DP24, P16298, Q17RY0, P51828, P27348, Q13362, Q14738 | MAD1L1, RPS6KA3, MAP2K1, CAMK2D, CALM1, CALM2, PPP3CB, CPEB4, ADCY7, YWHAQ, PPP2R5C, PPP2R5D | More | | Varenicline | hsa04120 | Ubiquitin mediated proteolysis | 7.75E-05 | 8 | Q9UBT2, Q14145, Q13042, P62837, Q15751, O95071, Q14669, P0CG47 | SAE2, KEAP1, CDC16, UBE2D2, HERC1, UBR5, TRIP12, UBB | More | | Varenicline | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Varenicline | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Varenicline | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Varenicline | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Varenicline | hsa04145 | Phagosome | 1.59E-03 | 7 | Q15080, P14598, Q13509, P68371, Q13488, O60603, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2, HLA-DOB | More | | Varenicline | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Varenicline | hsa04151 | PI3K-Akt signaling pathway | 1.65E-03 | 16 | P62753, P25116, O43521, P27348, P49767, Q13362, Q8WYR1, P62873, P16144, O60603, P01568, P18848, P10415, P17252, O00141, Q6ZUJ8 | RPS6, F2R, BCL2L11, YWHAQ, VEGFC, PPP2R5C, PIK3R5, GNB1, ITGB4, TLR2, IFNA21, ATF4, BCL2, PRKCA, SGK, PIK3AP1 | More | | Varenicline | hsa04152 | AMPK signaling pathway | 1.83E-02 | 3 | Q96RR4, Q13362, Q14738 | CAMKK2, PPP2R5C, PPP2R5D | More | | Varenicline | hsa04210 | Apoptosis | 3.63E-02 | 3 | O75460, O43521, P18848 | ERN1, BCL2L11, ATF4 | More | | Varenicline | hsa04213 | Longevity regulating pathway - multiple species | 2.70E-03 | 7 | P42338, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Varenicline | hsa04217 | Necroptosis | 6.15E-09 | 21 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, Q13546, P42224, Q14765, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, P10415, Q13557, Q9H444, O43633, O75351, Q08752 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, RIPK1, STAT1, STAT4, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, BCL2, CAMK2D, CHMP4B, CHMP2A, VPS4B, PPID | More | | Varenicline | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Varenicline | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.24E-06 | 14 | P09493, P07550, P63092, P51828, P22694, Q8WYR1, P18848, Q13362, Q14738, P0DP23, P0DP24, Q13557, P17252, P10415 | TPM1, ADRB2, GNAS, ADCY7, PRKACB, PIK3R5, ATF4, PPP2R5C, PPP2R5D, CALM1, CALM2, CAMK2D, PRKCA, BCL2 | More | | Varenicline | hsa04270 | Vascular smooth muscle contraction | 4.17E-04 | 8 | P0DP24, P0DP23, Q08828, P51828, P63092, P35579, P35749, P35318 | CALM2, CALM1, ADCY1, ADCY7, GNAS, MYH9, MYH11, ADM | More | | Varenicline | hsa04370 | VEGF signaling pathway | 1.79E-05 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Varenicline | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Varenicline | hsa04390 | Hippo signaling pathway | 5.79E-03 | 4 | P04628, Q9UJU2, O43623, Q13489 | WNT1, LEF1, SNAI2, BIRC3 | More | | Varenicline | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Varenicline | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Varenicline | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 4.73E-02 | 3 | Q13873, Q02750, Q86SE9 | BMPR2, MAP2K1, PCGF5 | More | | Varenicline | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Varenicline | hsa04612 | Antigen processing and presentation | 9.02E-05 | 8 | P13765, P01730, Q14953, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, CD4, KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Varenicline | hsa04613 | Neutrophil extracellular trap formation | 3.41E-04 | 14 | P17252, O60603, P08246, P04908, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P21462, O43315, Q16539 | PRKCA, TLR2, ELA2, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, FPR1, AQP9, MAPK14 | More | | Varenicline | hsa04622 | RIG-I-like receptor signaling pathway | 2.47E-02 | 1 | Q12933 | TRAF2 | More | | Varenicline | hsa04623 | Cytosolic DNA-sensing pathway | 1.53E-04 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Varenicline | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Varenicline | hsa04640 | Hematopoietic cell lineage | 1.47E-06 | 12 | P13612, P21926, P14778, P27930, P11215, P25063, P07766, P09693, P01732, P01730, P09564, P13765 | ITGA4, CD9, IL1R1, IL1R2, ITGAM, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB | More | | Varenicline | hsa04650 | Natural killer cell mediated cytotoxicity | 3.31E-10 | 15 | P16298, P50591, P19174, P01375, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O14931, P26717, Q14953, P26715 | PPP3CB, TNFSF10, PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, KLRC2, KIR2DS5, KLRC1 | More | | Varenicline | hsa04657 | IL-17 signaling pathway | 8.98E-04 | 7 | O00463, Q16539, P49841, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL2, MMP9, LCN2, TNF | More | | Varenicline | hsa04658 | Th1 and Th2 cell differentiation | 2.82E-10 | 12 | Q04759, P07766, P20963, P09693, P19174, P01730, P06239, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, CD4, LCK, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Varenicline | hsa04659 | Th17 cell differentiation | 2.90E-08 | 12 | Q04759, P19174, P01730, P06239, P14784, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Varenicline | hsa04660 | T cell receptor signaling pathway | 1.03E-05 | 11 | Q04759, P42338, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239 | PRKCQ, PIK3CB, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK | More | | Varenicline | hsa04664 | Fc epsilon RI signaling pathway | 3.98E-02 | 3 | P01375, Q16539, Q9UQC2 | TNF, MAPK14, GAB2 | More | | Varenicline | hsa04668 | TNF signaling pathway | 1.71E-04 | 9 | P01375, O00463, Q16539, P18848, P19875, P01584, P20749, P14780, P20333 | TNF, TRAF5, MAPK14, ATF4, CXCL2, IL1B, BCL3, MMP9, TNFRSF1B | More | | Varenicline | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Varenicline | hsa04713 | Circadian entrainment | 1.31E-03 | 8 | P0DP23, P0DP24, Q13557, P17252, P62873, Q14643, P51828, P63092 | CALM1, CALM2, CAMK2D, PRKCA, GNB1, ITPR1, ADCY7, GNAS | More | | Varenicline | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Varenicline | hsa04720 | Long-term potentiation | 1.56E-04 | 6 | P17252, P16298, P0DP23, P51812, Q02750, Q14643 | PRKCA, PPP3CB, CALM1, RPS6KA3, MAP2K1, ITPR1 | More | | Varenicline | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Varenicline | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Varenicline | hsa04725 | Cholinergic synapse | 1.83E-03 | 8 | P51828, Q14643, P17252, P62873, P18848, Q13557, P10415, Q8WYR1 | ADCY7, ITPR1, PRKCA, GNB1, ATF4, CAMK2D, BCL2, PIK3R5 | More | | Varenicline | hsa04728 | Dopaminergic synapse | 2.78E-04 | 10 | P63092, Q14643, P17252, P62873, P18848, Q13557, Q13362, Q14738, P0DP23, P0DP24 | GNAS, ITPR1, PRKCA, GNB1, ATF4, CAMK2D, PPP2R5C, PPP2R5D, CALM1, CALM2 | More | | Varenicline | hsa04744 | Phototransduction | 1.02E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Varenicline | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.21E-05 | 12 | P14778, P01584, P63092, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP24, P0DP23 | IL1R1, IL1B, GNAS, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM2, CALM1 | More | | Varenicline | hsa04911 | Insulin secretion | 7.99E-03 | 4 | P51828, P63092, P18848, Q13557 | ADCY7, GNAS, ATF4, CAMK2D | More | | Varenicline | hsa04912 | GnRH signaling pathway | 6.24E-04 | 8 | P17252, P51828, P18848, Q13557, Q14643, P0DP23, P0DP24, P63092 | PRKCA, ADCY7, ATF4, CAMK2D, ITPR1, CALM1, CALM2, GNAS | More | | Varenicline | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Varenicline | hsa04914 | Progesterone-mediated oocyte maturation | 7.22E-04 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Varenicline | hsa04915 | Estrogen signaling pathway | 3.17E-02 | 5 | Q08828, P51828, P0DMV8, P0DP23, Q15788 | ADCY1, ADCY7, HSPA1A, CALM1, NCOA1 | More | | Varenicline | hsa04916 | Melanogenesis | 7.99E-03 | 4 | Q13557, P0DP24, P63092, P51828 | CAMK2D, CALM2, GNAS, ADCY7 | More | | Varenicline | hsa04918 | Thyroid hormone synthesis | 4.75E-03 | 5 | P63092, P51828, P18848, P02768, P05543 | GNAS, ADCY7, ATF4, ALB, SERPINA7 | More | | Varenicline | hsa04921 | Oxytocin signaling pathway | 3.70E-03 | 8 | P0DP23, P0DP24, P51828, P63092, Q13557, Q96RR4, Q13469, Q8WYR1 | CALM1, CALM2, ADCY7, GNAS, CAMK2D, CAMKK2, NFATC2, PIK3R5 | More | | Varenicline | hsa04922 | Glucagon signaling pathway | 3.34E-03 | 8 | P63092, P18848, Q12778, Q13370, P0DP23, P0DP24, Q13557, Q14643 | GNAS, ATF4, FOXO1, PDE3B, CALM1, CALM2, CAMK2D, ITPR1 | More | | Varenicline | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Varenicline | hsa04924 | Renin secretion | 7.38E-04 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Varenicline | hsa04925 | Aldosterone synthesis and secretion | 4.75E-03 | 5 | P18848, P51828, P0DP24, P63092, Q13557 | ATF4, ADCY7, CALM2, GNAS, CAMK2D | More | | Varenicline | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | | Varenicline | hsa04927 | Cortisol synthesis and secretion | 1.61E-03 | 4 | P18848, P51828, P63092, P22694 | ATF4, ADCY7, GNAS, PRKACB | More | | Varenicline | hsa04930 | Type II diabetes mellitus | 2.47E-02 | 1 | Q02156 | PRKCE | More | | Varenicline | hsa04932 | Non-alcoholic fatty liver disease | 3.35E-09 | 13 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, P12074, O15239, Q16718, O95298, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFA5, NDUFC2, SDHD | More | | Varenicline | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.27E-02 | 5 | P42224, P10415, Q12778, P49767, P17252 | STAT1, BCL2, FOXO1, VEGFC, PRKCA | More | | Varenicline | hsa04934 | Cushing syndrome | 2.00E-02 | 4 | P18848, P51828, P63092, Q13557 | ATF4, ADCY7, GNAS, CAMK2D | More | | Varenicline | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Varenicline | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Varenicline | hsa04966 | Collecting duct acid secretion | 2.07E-03 | 3 | Q13488, P00918, Q9Y666 | TCIRG1, CA2, SLC12A7 | More | | Varenicline | hsa04970 | Salivary secretion | 2.25E-04 | 8 | P07550, P63092, Q08828, P51828, P22694, P0DP24, P0DP23, P49913 | ADRB2, GNAS, ADCY1, ADCY7, PRKACB, CALM2, CALM1, CAMP | More | | Varenicline | hsa04971 | Gastric acid secretion | 7.63E-04 | 5 | P51828, P63092, P15311, P0DP24, Q13557 | ADCY7, GNAS, VIL2, CALM2, CAMK2D | More | | Varenicline | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Varenicline | hsa04974 | Protein digestion and absorption | 2.47E-02 | 1 | Q7Z2H8 | SLC36A1 | More | | Varenicline | hsa04976 | Bile secretion | 3.14E-03 | 5 | O43315, Q08828, P51828, P08183, Q14032 | AQP9, ADCY1, ADCY7, ABCB1, BAAT | More | | Varenicline | hsa04979 | Cholesterol metabolism | 1.61E-02 | 2 | P38571, P61916 | LIPA, NPC2 | More | | Varenicline | hsa05010 | Alzheimer disease | 1.83E-04 | 17 | O15239, Q16718, O14521, P13073, P12074, Q14643, Q00535, O75460, P0DP23, P0DP24, P01584, P18848, Q13509, P68371, P05141, Q08752, P28070 | NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, ITPR1, CDK5, ERN1, CALM1, CALM2, IL1B, ATF4, TUBB3, TUBB2C, SLC25A5, PPID, PSMB4 | More | | Varenicline | hsa05012 | Parkinson disease | 3.18E-05 | 16 | O15239, Q16718, O14521, P13073, P12074, P05141, P63092, O75460, P18848, P28070, Q14643, P0DP23, P0DP24, Q13557, Q13509, P68371 | NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, SLC25A5, GNAS, ERN1, ATF4, PSMB4, ITPR1, CALM1, CALM2, CAMK2D, TUBB3, TUBB2C | More | | Varenicline | hsa05016 | Huntington disease | 9.21E-07 | 14 | O15239, O95298, P13073, P12074, Q9GZM3, P24928, P30876, P62487, P52435, P05141, Q9NYC9, O75460, P28070, O00232 | NDUFA1, NDUFC2, COX4I1, COX6A1, POLR2J2, POLR2A, POLR2B, POLR2G, POLR2J, SLC25A5, DNAH9, ERN1, PSMB4, PSMD12 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.777 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O95298 | NDUFC2 | NADH dehydrogenase [ubiquinone] 1 subunit C2 | 0.83 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.796 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.722 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.74 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.761 | P22001 | KCNA3 | Potassium voltage-gated channel subfamily A member 3 | Q9GZM3 | POLR2J2 | DNA-directed RNA polymerase II subunit RPB11-b1 | 0.76 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.751 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.784 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P24928 | POLR2A | DNA-directed RNA polymerase II subunit RPB1 | 0.714 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P30876 | POLR2B | DNA-directed RNA polymerase II subunit RPB2 | 0.832 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P30876 | POLR2B | DNA-directed RNA polymerase II subunit RPB2 | 0.795 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.855 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.855 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62487 | POLR2G | DNA-directed RNA polymerase II subunit RPB7 | 0.756 | P22001 | KCNA3 | Potassium voltage-gated channel subfamily A member 3 | P52435 | POLR2J | DNA-directed RNA polymerase II subunit RPB11-a | 0.76 | P22001 | KCNA3 | Potassium voltage-gated channel subfamily A member 3 | Q9GZM3 | POLR2J2 | DNA-directed RNA polymerase II subunit RPB11-b1 | 0.76 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.813 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P22001 | KCNA3 | Potassium voltage-gated channel subfamily A member 3 | Q9NYC9 | DNAH9 | Dynein axonemal heavy chain 9 | 0.785 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.785 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.79 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.749 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.85 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | O00232 | PSMD12 | 26S proteasome non-ATPase regulatory subunit 12 | -0.703 |
| Varenicline | hsa05020 | Prion disease | 2.20E-04 | 11 | Q16718, O14521, Q92736, Q14643, O60282, Q13509, P68371, P49841, P14598, Q15080, Q16539 | NDUFA5, SDHD, RYR2, ITPR1, KIF5C, TUBB3, TUBB2C, GSK3B, NCF1, NCF4, MAPK14 | More | | Varenicline | hsa05022 | Pathways of neurodegeneration - multiple diseases | 9.93E-07 | 24 | Q14643, Q13509, P68371, P49841, P10415, O15239, Q16718, O14521, P13073, P12074, O75460, P18848, Q13561, P05141, P17252, P20333, Q16539, Q00535, P01584, Q08752, P0DP23, P0DP24, Q13557, P28070 | ITPR1, TUBB3, TUBB2C, GSK3B, BCL2, NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, ERN1, ATF4, DCTN2, SLC25A5, PRKCA, TNFRSF1B, MAPK14, CDK5, IL1B, PPID, CALM1, CALM2, CAMK2D, PSMB4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.777 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.796 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.74 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.785 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.795 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.813 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.739 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P01584 | IL1B | Interleukin-1 beta | 0.816 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P0DP24 | CALM2 | Calmodulin-2 | 0.749 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.705 | Q9UBB5 | MBD2 | Methyl-CpG-binding domain protein 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.749 |
| Varenicline | hsa05030 | Cocaine addiction | 3.67E-02 | 3 | P63092, Q00535, P18848 | GNAS, CDK5, ATF4 | More | | Varenicline | hsa05031 | Amphetamine addiction | 1.16E-03 | 6 | P0DP24, Q13557, P22694, P63092, P18848, Q13547 | CALM2, CAMK2D, PRKACB, GNAS, ATF4, HDAC1 | More | | Varenicline | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Varenicline | hsa05100 | Bacterial invasion of epithelial cells | 1.82E-03 | 4 | Q14141, Q05397, Q92529, Q96JJ3 | SEPT6, PTK2, SHC3, ELMO2 | More | | Varenicline | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Varenicline | hsa05131 | Shigellosis | 3.33E-03 | 10 | Q12933, P68431, Q02156, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752 | TRAF2, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCE, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID | More | | Varenicline | hsa05132 | Salmonella infection | 2.14E-05 | 11 | Q9UJU2, O00471, Q13546, Q13489, P10415, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371 | LEF1, EXOC5, RIPK1, BIRC3, BCL2, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C | More | | Varenicline | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Varenicline | hsa05134 | Legionellosis | 8.80E-04 | 7 | P01584, Q9NR31, P11215, P0DMV8, P11142, P09341, P19875 | IL1B, SAR1A, ITGAM, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Varenicline | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Varenicline | hsa05140 | Leishmaniasis | 2.17E-03 | 6 | P14598, P42224, P13765, O60603, P29350, Q15080 | NCF1, STAT1, HLA-DOB, TLR2, PTPN6, NCF4 | More | | Varenicline | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Varenicline | hsa05144 | Malaria | 1.44E-03 | 5 | P69905, P68871, P01375, P35443, P26718 | HBA2, HBB, TNF, THBS4, KLRK1 | More | | Varenicline | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Varenicline | hsa05146 | Amoebiasis | 7.67E-07 | 12 | P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Varenicline | hsa05150 | Staphylococcus aureus infection | 1.91E-02 | 4 | Q14532, P59665, P59666, P49913 | KRT32, DEFA1; DEFA1B, DEFA3, CAMP | More | | Varenicline | hsa05152 | Tuberculosis | 7.93E-04 | 8 | Q13488, P0DP23, P42224, O60603, P10415, P13765, P01568, Q9UDY8 | TCIRG1, CALM1, STAT1, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Varenicline | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Varenicline | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Varenicline | hsa05163 | Human cytomegalovirus infection | 1.37E-04 | 18 | P01375, P0DP24, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P61073, Q13651, P25025, Q16539, P18848, P63092, O00463, P61769 | TNF, CALM2, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, CXCR4, IL10RA, CXCR2, MAPK14, ATF4, GNAS, TRAF5, B2M | More | | Varenicline | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Varenicline | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.23E-04 | 12 | P01568, P42224, P23458, P62873, P62879, Q13469, P16298, Q14643, Q02750, P0DP23, P0CG47, Q9UJU2 | IFNA21, STAT1, JAK1, GNB1, GNB2, NFATC2, PPP3CB, ITPR1, MAP2K1, CALM1, UBB, LEF1 | More | | Varenicline | hsa05168 | Herpes simplex virus 1 infection | 4.79E-02 | 8 | P25963, Q07955, Q01130, Q9Y2A4, P51522, P17038, P52738, O75820 | NFKBIA, SFRS1, SFRS2, ZNF443, ZNF83, ZNF43, ZNF140, ZNF189 | More | | Varenicline | hsa05169 | Epstein-Barr virus infection | 4.84E-03 | 10 | P13765, P01106, Q13547, O00463, P07948, Q13761, P24522, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, LYN, RUNX3, GADD45A, CD3E, CD3G, CD247 | More | | Varenicline | hsa05170 | Human immunodeficiency virus 1 infection | 8.44E-05 | 14 | Q02750, P62873, P62879, P16298, P0DP23, Q05397, P17252, Q14643, P01568, O60603, Q13315, P10415, Q9Y6Q5, P20333 | MAP2K1, GNB1, GNB2, PPP3CB, CALM1, PTK2, PRKCA, ITPR1, IFNA21, TLR2, ATM, BCL2, AP1M2, TNFRSF1B | More | | Varenicline | hsa05200 | Pathways in cancer | 9.44E-03 | 14 | P17301, P42224, Q9UJU2, P17252, P20585, P14923, P10415, Q13489, P49767, Q12778, P25116, P62873, P0DP23, P01568 | ITGA2, STAT1, LEF1, PRKCA, MSH3, JUP, BCL2, BIRC3, VEGFC, FOXO1, F2R, GNB1, CALM1, IFNA21 | More | | Varenicline | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Varenicline | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Varenicline | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Varenicline | hsa05212 | Pancreatic cancer | 4.16E-02 | 2 | Q15311, P23458 | RALBP1, JAK1 | More | | Varenicline | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Varenicline | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Varenicline | hsa05217 | Basal cell carcinoma | 4.31E-02 | 2 | P04628, Q9UJU2 | WNT1, LEF1 | More | | Varenicline | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Varenicline | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Varenicline | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 9.97E-06 | 9 | P42338, P19174, P07766, P20963, P09693, P06239, Q04759, Q9HC35, P01730 | PIK3CB, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, EML4, CD4 | More | | Varenicline | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Varenicline | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | | Varenicline | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 10 | P08246, P09871, P10747, P13765, P29965, Q6FI13, Q93077, P62807, O60814, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Varenicline | hsa05323 | Rheumatoid arthritis | 1.29E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | Varenicline | hsa05330 | Allograft rejection | 1.04E-03 | 5 | P13765, P29965, P48023, P10747, P01375 | HLA-DOB, CD40LG, FASLG, CD28, TNF | More | | Varenicline | hsa05332 | Graft-versus-host disease | 9.47E-05 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | | Varenicline | hsa05340 | Primary immunodeficiency | 1.31E-04 | 5 | P01730, P01732, P11912, P07766, P06239 | CD4, CD8A, CD79A, CD3E, LCK | More | | Varenicline | hsa05410 | Hypertrophic cardiomyopathy | 2.63E-02 | 1 | P17301 | ITGA2 | More | | Varenicline | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 3.44E-03 | 2 | P54284, P17301 | CACNB3, ITGA2 | More | | Varenicline | hsa05415 | Diabetic cardiomyopathy | 1.58E-03 | 7 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B | More | | Varenicline | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Varenicline | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |